APA (7th ed.) Citation

Divoux, J., Florent, R., Jacobs, M., Lequesne, J., Grellard, J., San, C., . . . Rousseau, N. (2023). The TRIPLEX study: Use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-11362-8

Chicago Style (17th ed.) Citation

Divoux, Jordane, et al. "The TRIPLEX Study: Use of Patient-derived Tumor Organoids as an Innovative Tool for Precision Medicine in Triple-negative Breast Cancer." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-11362-8.

MLA (9th ed.) Citation

Divoux, Jordane, et al. "The TRIPLEX Study: Use of Patient-derived Tumor Organoids as an Innovative Tool for Precision Medicine in Triple-negative Breast Cancer." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-11362-8.